About Caladan Bio
Caladan Bio is a company based in Brooklyn (United States) founded in 2023 by Rob Jauquet and Michael Kobida. Caladan Bio has raised $5.11 million across 1 funding round from investors including Lerer Hippeau, Twelve Below and Collab Fund. Caladan Bio operates in a competitive market with competitors including Unibio, MicrofluidX, Univercells Tech, Nirrin Technologies and Pow.Bio, among others.
- Headquarter Brooklyn, United States
- Founders Rob Jauquet, Michael Kobida
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.11 M (USD)
in 1 rounds
-
Latest Funding Round
$5.11 M (USD), Seed
Feb 02, 2024
-
Investors
Lerer Hippeau
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Caladan Bio
Caladan Bio has successfully raised a total of $5.11M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.11 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Caladan Bio
Caladan Bio has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Lerer Hippeau, Twelve Below and Collab Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A seed stage venture capital fund is operated by Twelve Below.
|
Locked | Locked | Locked | |
|
USA focused VC firm investing in seed and early stage startups
|
Locked | Locked | Locked | |
|
Private equity firm investing in multiple sectors
|
Locked | Locked | Locked |
Investor details for Caladan Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caladan Bio
Investment portfolio details for Caladan Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Caladan Bio
Detailed financials for Caladan Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caladan Bio Comparisons
Peer comparison for Caladan Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caladan Bio
Caladan Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unibio, MicrofluidX, Univercells Tech, Nirrin Technologies and Pow.Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal feed supplements are produced using proprietary fermentation technology.
|
|
| Locked | Locked | Locked |
MFX offers technology updates for the Cyto Engine product through its website.
|
|
| Locked | Locked | Locked |
Intensified biomanufacturing technologies for viral production are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of sensor and integration technologies for continuous control and bioprocess automation
|
|
| Locked | Locked | Locked |
Intelligent fermentation services for industrial and synthetic biology are provided.
|
Detailed competitors of Caladan Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caladan Bio
Complete news archive for Caladan Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caladan Bio
Caladan Bio was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Caladan Bio is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Michael Kobida is the current CEO of Caladan Bio. They have also founded this company.
Caladan Bio is a funded company, having raised a total of $5.11M across 1 funding round to date.
Caladan Bio was founded in 2023 and is based in Brooklyn, United States. Bioreactors for biotechnology research are developed by the company, with a focus on next-generation models. Modular and affordable technology is provided through these bioreactors to support research operations in the biotechnology sector. Co-founders Rob Jauquet and Michael Kobida lead the efforts in this domain.
Caladan Bio's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
Caladan Bio has 6 investors. Key investors include Lerer Hippeau, Twelve Below, Collab Fund, Wireframe Ventures, and Ritual Capital.